SCHEMBL26847290

SCHEMBL26847290

N#Cc1c(Cc2ccccc2)cc(=O)[nH]c1SCC1=NCC(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 8/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ HPGD P15428 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HSD11B2 P80365 1/20 0.36
▸ CXCR2 P25025 1/20 0.36
▸ ACMSD Q8TDX5 2/20 0.35
▸ RAPGEF4 Q8WZA2 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ TNF P01375 1/20 0.34
▸ NOD2 Q9HC29 1/20 0.34
▸ NOD1 Q9Y239 1/20 0.34
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087880 0.77 ALDH1A1 (0.42) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL26847205 0.77 KMT2A (0.43) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL20340159 0.76 ALDH1A1 (0.39) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL24087897 0.76 ALDH1A1 (0.39) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL20340210 0.76 KDM4E (0.58) ALDH1A1KMT2AHPGDGAALMNA
SCHEMBL23849883 0.75 ACMSD (0.48) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL20340101 0.75 ACMSD (0.57) ALDH1A1KMT2AHPGDACMSDMEN1
SCHEMBL26847291 0.75 ALDH1A1 (0.44) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL24087949 0.75 ALDH1A1 (0.44) HSD11B1ALDH1A1KMT2AHPGDGAA
SCHEMBL26847297 0.75 ALDH1A1 (0.44) HSD11B1ALDH1A1KMT2AHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 HSD11B1 1734/4885ALDH1A1 171/4885KMT2A 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback